(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPTISANA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPTISANA

ST13

US500000079223301

Class

5

Filing

79223301

Registration

5609086

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

02/07/2026

Trademark type

Word

Nice classes

5

Filing date

10/27/2017

Registration date

11/20/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/06/2025

Last transaction

02/07/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

30

Owner location

DE

Examiner

BENMAMAN, ALICE

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Lidl Stiftung & Co. KG

Representatives

Scott Greenberg Culhane Meadows PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations for weight control and immune health; sanitary preparations for medical purposes; vitamin and mineral preparations for medical use; dietetic foods adapted for medical purposes; food supplements

Publications

History of USPTO decisions and trademark events.

37 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

02/06/2026

C71T

CANCELLED SECTION 71

06/06/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/30/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/20/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/06/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/06/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/06/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/06/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/21/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/23/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/22/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/04/2019

FIMP

FINAL DISPOSITION PROCESSED

03/04/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/20/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

11/20/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/04/2018

PUBO

PUBLISHED FOR OPPOSITION

09/04/2018

GPNX

NOTIFICATION PROCESSED BY IB

08/31/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/15/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/15/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/15/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/27/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/26/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/26/2018

ALIE

ASSIGNED TO LIE

07/26/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/12/2018

RFNT

REFUSAL PROCESSED BY IB

02/10/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/24/2018

RFRR

REFUSAL PROCESSED BY MPU

01/24/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/17/2018

CNRT

NON-FINAL ACTION WRITTEN

01/16/2018

DOCK

ASSIGNED TO EXAMINER

01/16/2018

MAFR

APPLICATION FILING RECEIPT MAILED

12/23/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/19/2017

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

12/14/2017

Continuous trademark protection

Get notified about every new filing that threatens OPTISANA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.